Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Medical Imaging Development (AMID) is an Italian MedTech company specializing in the development of advanced software for cardiovascular imaging and mechanics. Founded in 2000 and acquired by Medis Medical Imaging Systems in 2020, the company provides vendor-independent solutions for the accurate quantification of cardiac function across multiple modalities, including ultrasound, MRI, CT, and X-ray. Its flagship technologies include high-definition blood flow tracking for echocardiography and innovative image processing tools that have become industry standards in cardiovascular research and clinical diagnosis. AMID's software is integrated into devices from leading global medical imaging manufacturers such as Siemens, Esaote, and Samsung to support clinicians in making precise diagnostic and treatment decisions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Medical Imaging Development.